期刊文献+

原发性高血压6个相关基因的研究 被引量:2

Analysis of 6 Candidate Genes of Essential Hypertension
下载PDF
导出
摘要 目的探讨中国人群中血管紧张素原等6个原发性高血压(EHT)候选基因的基因型和单体型分布情况及与EHT的关系。方法采用基因芯片技术和Phase v 2.1单体型分析软件检测和分析264例EHT患者和319例健康对照者包括AGT、ACE、NOS3等在内的涉及肾素-血管紧张素-酮固酮系统(RAAS)和内皮功能相关的6个基因的基因型和单体型。结果中国人群中AGT等6个基因的等位基因频率分布具有中国特色。EHT组和健康对照组的ACEA luI/D基因型和ANP2238C/T等位基因频率分布差异有统计学意义(P分别为0.011和0.039);单体型则以RE-1(50%)和RE-8(20.4%)为主;两组间分布差异有统计学意义的有RE-1、RE-2和RE-3(P分别为0.019,0.035,0.037)。结论AGT等6个基因的基因型分布具有种族和地区差异,ACEA luI/D和ANP2238C/T可能与中国人群原发性高血压有关;单体型RE-1是高血压产生的危险因素,而RE-2、RE-10则有保护作用。 Objective To investigate the distribution of 6 essential hypertension(EHT) candidate genes' genotypes and haplotypes and analyze the association with EHT. Methods With gene array technology and the haplotye analysis software (Phase v 2.1),the genotypes and haplotyes in 264 EHT patients and 319 healthy controls were detected and analyzed. Results 6 EHT' s candidate genes' allele frequency in Chinese was different from that of other countries and areas;the differences between EHT patients and healthy control about ACE^Alu I/D and ANP^2238 C/T allele genes' frequencies was statistically significant (P = 0. 011,0. 039 , respectively) ,the haplotyoe RE-1 and 8 were the main haplotypes in Chinese people. The frequencies of RE-1,2 and 10 in EHT patients were different from those of healthy controls in statistics. Conclusion The alleles frequencies of 6 genes were different among different countries and areas. ACE^Alu I/D, ANP^2238 C/T might contribute to the onset and progression of EHT. Among them,RE-2 and RE-10 played a protective role;and RE-1 was risk factor.
出处 《中华全科医学》 2009年第7期670-671,674,共3页 Chinese Journal of General Practice
基金 广东省深圳市07年科研课题项目(200702006)
关键词 原发性高血压 候选基因 基因芯片 单体型 Essential hypertension Candidate gene Gene array Haplotype
  • 相关文献

参考文献13

  • 1罗泽伟.群体遗传学[M]//陈竺.医学遗传学(七年制).北京:人民卫生出版社,2001:104-105.
  • 2Chcn Zhu. Medical Genetics [ M ]. Bei Jing:Feople's medical publish- ing house 92091 : 104-105.
  • 3Stephens M,Smith N, Donnelly P. A new statistical method for haplotype reconstruction from population data[ J]. American Journal of Human Genetics,2001,68:978-989.
  • 4Stephens M, Donnelly P. A comparison of Bayesian methods for haplotype reconstruction from population genotype data [ J ]. American Journal of Human Genetics ,2003,73 : 1162-1169.
  • 5Sharma P, Hingorani A ,Jia H, et al. Quantitative association between a newly identified molecular variant in the endothelin-2 gene and human essential hypertension[ J]. J Hypertens, 1999,17 (9) : 1281-1287.
  • 6Speranza Rubattu, Paul Ridker, Meir J. Stampfer, et al. The Gene Encoding Atrial Natriuretic Peptide and the Risk of Human Stroke [ J ]. Circulation, 1999,100 : 1722-1726.
  • 7Sarzani R, Dessi-Fulgheri P, Salvi F. A novel promoter variant of the natriuretic peptide clearance receptor gene is associated with lower atrial natriuretic peptide and higher blood pressure in obese hypertensives[ J ]. J Hypertens, 1999,17 (9) : 1301-1305.
  • 8Kehoe PG, Katzov H, Andreasen N, et al. Common variants of ACE contribute to variable age-at-onset of Alzheimer' s disease [ J ]. Hum Genet, 2004,114:478-483.
  • 9Elkins JS, Douglas VC ,Johnston SC. Alzheimer disease risk and genetic variation in ACE : a meta-analysis [ J ]. Neurology, 2004,62 : 363- 368.
  • 10Slowik A,Turaj W,Dziedzic T,et al. DD genotype of ACE gene is a risk factor for intracerebral hemorrhage [ J ]. Neurology, 2004,63: 359-361.

共引文献1

同被引文献22

  • 1石光清,向谷良,戴中伟,邱娟,郭肖南.血浆肾素、血管紧张素II、醛固酮含量在原发性高血压病患者治疗前后的临床意义[J].实用预防医学,2005,12(6):1297-1298. 被引量:4
  • 2Spiegeloman B M. PPAR adipogenic regulator and thiazolidinedione receptor[J]. Diabetes, 1998,47(4) : 507-514.
  • 3Holzapfel J, Heun R, Ltitjohann D, et al. PPARD haplotype influences cholesterol metabolism but is no risk factor of Alzheimer's disease[J]. Neurosci Lett,2006,408(1):57-61.
  • 4Komatsu A, Node K. Effects of PPARgamma agonist on dyslipidemia and atherosclerosis [J]. Nippon Rinsho, 2010, 68 (2) :294-298.
  • 5Eckel R H, Grundy S M, Zimmet P Z. The metabolic syndrome [J]. Lancet,2005,365(9468): 1415-1428.
  • 6Azhar S. Peroxisome proliferator-acti-ated receptors, metaboliesyndrome and cardio-ascular disease [J ]. Future Cardiol,2010,6(5) :657-691.
  • 7Hara K, Okada T, Tobe K, et al. The prol2Ala polymorphism in PPAR gamma2 may confer resistance to type 2 diabetes[J]. Biochem Biophys Res Commun, 2000,271 (1) 212-216.
  • 8Ristow M, Mtiller-Wieland D, Pfeiffer A, et al. Obesity associated with a mutation in a genetic regulator of adipocyte differentiation[J]. N Engl J Med, 1998,339 (14) : 953-959.
  • 9Wang X L, Oosterhof J, Duarte N. Peroxisome proliferator- acti-ated receptor gamma C161- T polymorphism and coronary artery disease[-J]. Cardio-ase Res, 1999,44 (3) : 588- 594.
  • 10Benkirane K, Viel E C, Amiri F, et al. Peroxisome proliferator acti-ated receptor gamma regulates angiotensin 1I- stimulated phosphatidylinositol 3-kinase and mitogen-acti-ated protein kinase in blood -essels in -i-o [J]. Hypertension, 2006, 47(1) :102-108.

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部